SARS-COV-2
Clinical trials for SARS-COV-2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 trials appear
Sign up with your email to follow new studies for SARS-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
COVID vaccine trial for babies under 6 months halted early
⭐️ VACCINE ⭐️ TerminatedThis study tested an updated mRNA COVID-19 vaccine (mRNA-1273.214) in healthy infants between 12 weeks and under 6 months old. The goal was to check for side effects and see how well the vaccine worked. The study was stopped early, but the information gathered helps researchers u…
Matched conditions: SARS-COV-2
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 07:07 UTC
-
COVID-19 antibody combo study halted early
Disease control TerminatedThis study tested a combination of two antibodies (REGN14256 and imdevimab) in adults with mild COVID-19 who were not at high risk for severe illness. The goal was to see if the treatment was safe and could reduce the amount of virus in the body. The study was stopped early, and …
Matched conditions: SARS-COV-2
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
HIV drug fails to prevent COVID in High-Risk healthcare workers
Prevention TerminatedThis study tested whether a daily pill (TAF/FTC), normally used for HIV, could prevent COVID-19 in healthcare workers at high risk of exposure. About 1,378 participants were randomly assigned to receive the drug or a placebo. The trial was terminated early, and the results did no…
Matched conditions: SARS-COV-2
Phase: PHASE3 • Sponsor: Hospital Italiano de Buenos Aires • Aim: Prevention
Last updated May 15, 2026 11:53 UTC